Kenneth Carl Anderson - 26 Jan 2022 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
26 Jan 2022
Net transactions value
+$8,338
Form type
4
Filing time
26 Jan 2022, 16:26:13 UTC
Previous filing
18 Jan 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Options Exercise $1,694 +803 +0.94% $2.11 86,641 26 Jan 2022 Direct
transaction CCCC Common Stock Options Exercise $6,643 +1,334 +1.5% $4.98 87,975 26 Jan 2022 Direct
holding CCCC Common Stock 47,316 26 Jan 2022 By Spouse
holding CCCC Common Stock 61,265 26 Jan 2022 By Kenneth C. Anderson 2016 Grantor Retained Annuity Trust F1
holding CCCC Common Stock 61,265 26 Jan 2022 By Cynthia E. Anderson 2016 Grantor Retained Annuity Trust F2
holding CCCC Common Stock 16,939 26 Jan 2022 By Kenneth C. Anderson 2015 Irrevocable Trust F3
holding CCCC Common Stock 16,939 26 Jan 2022 By Cynthia E. Anderson 2015 Irrevocable Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Options Exercise $0 -803 -27% $0.000000 2,137 26 Jan 2022 Common Stock 803 $2.11 Direct F5
transaction CCCC Stock Option (Right to Buy) Options Exercise $0 -1,334 -33% $0.000000 2,668 26 Jan 2022 Common Stock 1,334 $4.98 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4 Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F5 12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter.
F6 The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020.